Langzeit-Augmentationstherapie von Patienten mit Alpha-1-Antitrypsin-Mangel in der häuslichen Pflege

Abstract

Home care with i. v. augmentation therapy by medical professionals contributes to optimum care through consistent treatment and close health-status monitoring in our collective. Exacerbation-related hospitalizations were largely avoided. "Alpha-1-Mobile" was well accepted, practical, and safe.

Alpha-1 Antitrypsin Deficiency: Home Therapy

“…Again, a home-based administration is safe and demonstrates no side effects. According to the results of other studies, home care is also practicable for several years (Wilke et al, 2018). Limitations of the study are the use of a reduced version of the SGRQ currently not validated and the small number of patients.…”

Diagnosis and management of α1-antitrypsin deficiency in Europe: an expert survey

“…bi-weekly) and home treatment are already used in some European countries [28, 39]. In addition to the national home treatment programmes reported here, a third party-sponsored Berlin-based programme in Germany has reported successful results in terms of improving patient monitoring and reducing exacerbation-related hospitalisations in a small pilot study [40]. Self-administration is likely to be beneficial for subsets of AATD patients and could help reduce costs associated with treatment.…”